Sigyn Therapeutics, Inc. (SIGY)
About Sigyn Therapeutics, Inc.
SIGYN THERAPEUTICS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2019
- $143.3K
- Net income
- -$3.3M
- Total assets
- $213.7K
Source: SEC EDGAR · updated Jun 8, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Sigyn Therapeutics, Inc. (SIGY) Stock Price
- Reported a net loss of $3.3M in FY2019.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Sigyn Therapeutics, Inc..
Write a review
Sigyn Therapeutics, Inc.: frequently asked questions
Is Sigyn Therapeutics, Inc. an American company?
Sigyn Therapeutics, Inc. is a US-based company headquartered in Beverly Hills, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Sigyn Therapeutics, Inc. headquartered?
Sigyn Therapeutics, Inc. is headquartered in Beverly Hills, California, United States.
Is Sigyn Therapeutics, Inc. publicly traded?
Yes — Sigyn Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol SIGY on the OTC.
What does Sigyn Therapeutics, Inc. do?
Sigyn Therapeutics, Inc. is an American Medical Devices company in the Health & Beauty sector.
